Noscira SA clinical trials
A subsidiary of PharmaMar
The registry lists 3 studies whose lead sponsor is Noscira SA. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2012.
Registry sponsor names on this page
- Noscira SA3 studies
Something wrong with this grouping? Tell us on the PharmaMar page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All PharmaMar studies →
- Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease PatientsCompletedNCT01350362Phase 2
Sponsor listed in the registry: Noscira SA
- Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear PalsyCompletedNCT01049399Not applicable
Sponsor listed in the registry: Noscira SA
- Safety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s DiseaseCompletedNCT00948259Phase 1/2
Sponsor listed in the registry: Noscira SA